{"id":2052,"date":"2024-06-02T09:54:01","date_gmt":"2024-06-02T09:54:01","guid":{"rendered":"https:\/\/www.msd.cz\/cs\/?page_id=2052"},"modified":"2026-04-22T14:04:20","modified_gmt":"2026-04-22T14:04:20","slug":"informace-o-produktech","status":"publish","type":"page","link":"https:\/\/www.msd.cz\/cs\/lidske-zdravi\/informace-o-produktech\/","title":{"rendered":"Informace o produktech"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t\n\t\t\t

Informace o produktech<\/h2>\n\n\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n

Seznam produkt\u016f<\/strong><\/h2>\n\n\n\n

Investujeme miliardy dolar\u016f do v\u00fdzkumu a v\u00fdvoje l\u00e9k\u016f, kter\u00e9 zachra\u0148uj\u00ed a zlep\u0161uj\u00ed lidsk\u00e9 \u017eivoty. Poskytujeme na l\u00e9ka\u0159sk\u00fd p\u0159edpis \u0159adu p\u0159\u00edpravk\u016f v kl\u00ed\u010dov\u00fdch l\u00e9\u010debn\u00fdch oblastech, jako jsou onkologie, imunologie, vakc\u00edny, infek\u010dn\u00ed choroby, diabetologie, kardiologie a anesteziologie.<\/p>\n\n\n\n

Adempas<\/strong> (riocigu\u00e1t)<\/p>\n\n\n\n

Bridion<\/strong> (sodn\u00e1 s\u016fl sugammadexu)<\/p>\n\n\n\n

Cancidas<\/strong> (kaspofungin-diacet\u00e1t)<\/p>\n\n\n\n

Capvaxive<\/strong> (konjugovan\u00e9 pneumokokov\u00e9 polysacharidy s\u00e9rotypu 3, 6a, 7f, 8, 9n, 10a,11a, 12f, 15a, de-O-acetylovan\u00fd 15B, 16f, 17f, 19a, 20a, 22f, 23a, 23b, 24f, 31, 33f a 35b)<\/p>\n\n\n\n

Cubicin<\/strong> (daptomycin)<\/p>\n\n\n\n

Delstrigo<\/strong> (doravirin, lamivudin , tenofovir-disoproxil-fumar\u00e1t)<\/p>\n\n\n\n

Efficib<\/strong> (monohydr\u00e1t sitagliptin-fosf\u00e1tu, metformin-hydrochlorid)<\/p>\n\n\n\n

Emend <\/strong>(aprepitant)<\/p>\n\n\n\n

Enflonsia<\/strong> (klesrovimab)<\/p>\n\n\n\n

Ervebo <\/strong>(\u017eiv\u00fd oslaben\u00fd virus zairsk\u00e9 eboly rVSV\u2206G-ZEBOV-GP)<\/p>\n\n\n\n

Esmeron<\/strong> (rokuronium-bromid)<\/p>\n\n\n\n

Gardasil <\/strong>(L1 protein lidsk\u00e9ho papilomaviru typu 6, 11, 16 a 18)<\/p>\n\n\n\n

Gardasil 9<\/strong> (L1 protein lidsk\u00e9ho papilomaviru typu 6, 11, 16, 18, 31, 33, 45, 52 a 58)<\/p>\n\n\n\n

HBVAXPRO<\/strong> (rekombinantn\u00ed povrchov\u00fd antigen hepatitidy B)<\/p>\n\n\n\n

Invanz<\/strong> (ertapenem)<\/p>\n\n\n\n

Isentress<\/strong> (draseln\u00e1 s\u016fl raltegraviru)<\/p>\n\n\n\n

Ivemend<\/strong> (fosaprepitant-dimeglumin)<\/p>\n\n\n\n

Janumet<\/strong> (monohydr\u00e1t sitagliptin-fosf\u00e1tu, metformin-hydrochlorid)<\/p>\n\n\n\n

Januvia<\/strong> (monohydr\u00e1t sitagliptin-fosf\u00e1tu)<\/p>\n\n\n\n

Keytruda<\/strong> (pembrolizumab)<\/p>\n\n\n\n

Lagevrio<\/strong> (molnupiravir)<\/p>\n\n\n\n

Lyfnua<\/strong> (gefapixant-citr\u00e1t)<\/p>\n\n\n\n

M-M-RVAXPRO<\/strong> (\u017eiv\u00e9 oslaben\u00e9 viry spalni\u010dek, p\u0159\u00edu\u0161nic a zard\u011bnek)<\/p>\n\n\n\n

Noxafil<\/strong> (posakonazol)<\/p>\n\n\n\n

Pifeltro <\/strong>(doravirin)<\/p>\n\n\n\n

Pneumovax23<\/strong> (pneumokokov\u00e9 polysacharidy typu 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19f, 19a, 20, 22f, 23f a 33f)<\/p>\n\n\n\n

Prevymis<\/strong> (letermovir)<\/p>\n\n\n\n

ProQuad<\/strong> (\u017eiv\u00e9 oslaben\u00e9 viry spalni\u010dek, p\u0159\u00edu\u0161nic, zard\u011bnek a plan\u00fdch ne\u0161tovic)<\/p>\n\n\n\n

Recarbrio<\/strong> (monohydr\u00e1t imipenemu, sodn\u00e1 s\u016fl cilastatinu, monohydr\u00e1t relebaktamu)<\/p>\n\n\n\n

Ristaben<\/strong> (monohydr\u00e1t sitagliptin-fosf\u00e1tu)<\/p>\n\n\n\n

Ristfor <\/strong>(monohydr\u00e1t sitagliptin-fosf\u00e1tu, metformin-hydrochlorid)<\/p>\n\n\n\n

RotaTeq <\/strong>(\u017eiv\u00fd rotavirus s\u00e9rotypu G1, G2, G3, G4 a P1A[8])<\/p>\n\n\n\n

Segluromet<\/strong> (ertugliflozin s kyselinou pidolovou, metformin-hydrochlorid)<\/p>\n\n\n\n

Sivextro<\/strong> (natrium-tedizolid-fosf\u00e1t)<\/p>\n\n\n\n

Steglujan<\/strong> (ertugliflozin s kyselinou pidolovou, monodr\u00e1t sitagliptin-fosf\u00e1tu)<\/p>\n\n\n\n

Steglatro<\/strong> (ertugliflozin s kyselinou pidolovou)<\/p>\n\n\n\n

Temodal<\/strong> (temozolomid)<\/p>\n\n\n\n

Tesavel <\/strong>(monohydr\u00e1t sitagliptin-fosf\u00e1tu)<\/p>\n\n\n\n

Vaxneuvance<\/strong> (konjugovan\u00e9 pneumokokov\u00e9 polysacharidy typu 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f a 33f)<\/p>\n\n\n\n

Vaqta<\/strong> (inaktivovan\u00fd virus hepatitidy A)<\/p>\n\n\n\n

Varivax<\/strong> (\u017eiv\u00fd oslaben\u00fd virus plan\u00fdch ne\u0161tovic)<\/p>\n\n\n\n

Vaxelis <\/strong>(toxoid z\u00e1\u0161krtu, toxoid tetanu, antigeny bakterie Bordetella pertussis (toxoid d\u00e1viv\u00e9ho ka\u0161le (PT)), filament\u00f3zn\u00ed hemaglutinin d\u00e1viv\u00e9ho ka\u0161le (FHA), pertaktin (PRN), fimbrie typu 2 a 3 (FIM), povrchov\u00fd antigen viru hepatitidy B, inaktivovan\u00fd virus poliomyelitidy typu 1, 2 a 3, konjugovan\u00fd polysacharid bakterie Haemophilus influenzae typu b)<\/p>\n\n\n\n

Velmetia<\/strong> (monohydr\u00e1t sitagliptin-fosf\u00e1tu, metformin-hydrochlorid)<\/p>\n\n\n\n

Welireg<\/strong> (belzutifan)<\/p>\n\n\n\n

Winrevair<\/strong> (sotatercept)<\/p>\n\n\n\n

Xelevia <\/strong>(monohydr\u00e1t sitagliptin-fosf\u00e1tu)<\/p>\n\n\n\n

Zepatier<\/strong> (elbasvir, grazoprevir)<\/p>\n\n\n\n

Zerbaxa<\/strong> (ceftolozan-sulf\u00e1t, sodn\u00e1 s\u016fl tazobaktamu)<\/p>\n\n\n\n

Zinplava<\/strong> (bezlotoxumab)<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n

VPOIS<\/strong><\/h2>\n\n\n\n

Vstoupili jste do ve\u0159ejn\u011b p\u0159\u00edstupn\u00e9 \u010d\u00e1sti, kter\u00e1 obsahuje informace o v\u0161ech l\u00e9\u010div\u00fdch p\u0159\u00edpravc\u00edch dr\u017eitel\u016f zastupovan\u00fdch spole\u010dnost\u00ed Merck Sharp & Dohme s.r.o.<\/p>\n\n\n\n

Povinnost z\u0159\u00eddit tuto \u201cVe\u0159ejn\u011b p\u0159\u00edstupnou odbornou informa\u010dn\u00ed slu\u017ebu \u2013 VPOIS\u201d vypl\u00fdv\u00e1 ze z\u00e1kona \u010d. 378\/2007 Sb., o l\u00e9\u010divech, v platn\u00e9m zn\u011bn\u00ed (\u00a7 33 odst. 3 p\u00edsm. g) bod 1.). Aktu\u00e1ln\u00ed informace o jednotliv\u00fdch p\u0159\u00edpravc\u00edch, stanoven\u00e9 \u00fahrad\u011b a o jejich dostupnosti naleznete na str\u00e1nk\u00e1ch St\u00e1tn\u00edho \u00fastavu pro kontrolu l\u00e9\u010div v datab\u00e1zi l\u00e9k\u016f zde<\/a>.<\/p>\n\n\n\n

Informace o p\u0159\u00edpravku (Souhrn \u00fadaj\u016f o p\u0159\u00edpravku nebo P\u0159\u00edbalov\u00e1 informace) lze nal\u00e9zt v datab\u00e1zi nejl\u00e9pe zad\u00e1n\u00edm n\u00e1zvu p\u0159\u00edpravku do vyhled\u00e1vac\u00edho pole na z\u00e1lo\u017ece L\u00e9\u010diva dle registra\u010dn\u00edho \u010d\u00edsla<\/strong>, pot\u00e9 kliknut\u00edm na Vyhledat <\/strong>a po dal\u0161\u00edm n\u00e1sledn\u00e9m kliknut\u00ed na \u0159\u00e1dek odpov\u00eddaj\u00edc\u00ed hledan\u00e9mu p\u0159\u00edpravku.<\/p>\n\n\n\n

Informace o stanoven\u00e9 \u00fahrad\u011b a dostupnosti na trhu lze nal\u00e9zt v datab\u00e1zi nejl\u00e9pe zad\u00e1n\u00edm n\u00e1zvu p\u0159\u00edpravku do vyhled\u00e1vac\u00edho pole na z\u00e1lo\u017ece L\u00e9\u010diva dle k\u00f3du S\u00daKL<\/strong>, pot\u00e9 kliknut\u00edm na Vyhledat <\/strong>a po dal\u0161\u00edm n\u00e1sledn\u00e9m kliknut\u00ed na \u0159\u00e1dek odpov\u00eddaj\u00edc\u00ed hledan\u00e9mu p\u0159\u00edpravku.<\/p>\n\n\n\n

M\u011bjte, pros\u00edm, rovn\u011b\u017e v patrnosti, \u017ee Informace o p\u0159\u00edpravku v \u017e\u00e1dn\u00e9m p\u0159\u00edpad\u011b nenahrazuje pokyny l\u00e9ka\u0159e nebo l\u00e9k\u00e1rn\u00edka.<\/p>\n\n\n\n

Pro p\u0159\u00edpad, \u017ee n\u011bkter\u00fd z v\u00fd\u0161e uveden\u00fdch l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f bude ozna\u010den p\u0159\u00edznakem \u201eomezen\u00e1 dostupnost\u201c, plat\u00ed, \u017ee jeho distribuci na trhu v \u010cesk\u00e9 republice pro dr\u017eitele rozhodnut\u00ed o registraci zaji\u0161\u0165uje spole\u010dnost Merck Sharp & Dohme s.r.o.<\/p>\n\n\n\n

Informa\u010dn\u00ed slu\u017eba pro nevidom\u00e9 a slabozrak\u00e9 je dostupn\u00e1 na tel +420 277 050 000<\/a>.<\/p>\n\n\n\n

V p\u0159\u00edpad\u011b dotaz\u016f na konkr\u00e9tn\u00ed p\u0159\u00edpravek z portfolia MSD n\u00e1s kontaktujte na adrese Merck Sharp & Dohme s.r.o., Na Valentince 3336\/4, 150 00 Praha 5, \u010cesk\u00e1 republika nebo e-mailem na dpoc_czechslovak@msd.com<\/a>, \u010di telefonicky na \u010d\u00edsle: +420 277 050 000<\/a>.<\/p>\n\n\n\n

<\/p>\n\n\n